Bone Solutions, Inc. FDA Approvals

0 new drug approvals and 6 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product	What it is	Route	Decided
Mg OSTEOREVIVE;Mg OSTEOCRETE510(k)Sep 11, 2026Orthopedic	Orthopedic	510(k)Substantially Equivalent (Traditional)	Sep 11, 2026
Mg OSTEOINJECT; Mg OSTEOREVIVE; Mg OSTEOCRETE510(k)Oct 13, 2025Orthopedic	Orthopedic	510(k)Substantially Equivalent (Traditional)	Oct 13, 2025
Mg OSTEOREVIVE, Mg OSTEOCRETE510(k)Oct 18, 2024Orthopedic	Orthopedic	510(k)Substantially Equivalent (Traditional)	Oct 18, 2024
Mg OSTEOINJECT; Mg OSTEOREVIVE; Mg OSTEOCRETE510(k)Feb 5, 2024Orthopedic	Orthopedic	510(k)Substantially Equivalent (Traditional)	Feb 5, 2024
Mg OSTEOINJECT510(k)Jun 28, 2022Orthopedic	Orthopedic	510(k)Substantially Equivalent (Traditional)	Jun 28, 2022
Osteorevive510(k)Jan 21, 2022Orthopedic	Orthopedic	510(k)Substantially Equivalent (Traditional)	Jan 21, 2022